Inventor profile of:

Marc Abrams

City:

Natick, Massachusetts

Country:

United States

Published Applications:

22

Last publication date:

2026-05-28

Top Assignees for applications by Marc Abrams

The entities that hold a legal rights for patent applications filed by inventor Abrams Marc:

Recent patent applications by Abrams Marc

Marc Abrams from Natick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28
US20260146253A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION

#2 | 2026-03-12
US20260071219A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

#3 | 2026-02-19
US20260049309A1
Chemistry; metallurgy

REGULATION OF ACTIVITY OF RNAI MOLECULES

#4 | 2025-09-18
US20250290071A1
Chemistry; metallurgy

STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF

#5 | 2025-04-17
US20250122500A1
Chemistry; metallurgy

RNAi OLIGONUCLEOTIDE CONJUGATES

#6 | 2025-03-20
US20250092403A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)

#7 | 2024-12-05
US20240401059A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING PNPLA3 EXPRESSION

#8 | 2024-12-05
US20240401053A1
Chemistry; metallurgy

Compositions and methods for inhibiting LPA expression

#9 | 2024-10-17
US20240344063A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION

#10 | 2024-05-09
US20240150768A1
Chemistry; metallurgy

METHODS FOR THE TREATMENT OF NASH WITH ADVANCED FIBROSIS AND/OR CIRRHOSIS

#11 | 2024-05-02
US20240139230A1
Human necessities

DOSAGE REGIMEN FOR THE TREATMENT OF NASH

#12 | 2024-04-18
US20240124875A1
Chemistry; metallurgy

RNAI CONJUGATES AND USES THEREOF

#13 | 2023-12-07
US20230392148A1
Chemistry; metallurgy

REDUCING BETA-CATENIN EXPRESSION TO POTENTIATE IMMUNOTHERAPY

#14 | 2023-10-26
US20230340487A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC SYNDROME

#15 | 2023-09-14
US20230287425A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 EXPRESSION

#16 | 2023-09-07
US20230277675A1
Human necessities

SYSTEMIC DELIVERY OF OLIGONUCLEOTIDES

#17 | 2023-06-22
US20230190753A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER

#18 | 2022-11-17
US20220364098A1
Chemistry; metallurgy

Compositions and methods for modulating PNPLA3 expression

#19 | 2022-10-27
US20220340909A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)

#20 | 2021-01-21
US20210015820A1
Human necessities

Compositions and methods for the treatment of a beta-catenin-associated disease or disorder

#21 | 2020-12-03
US20200377882A1
Chemistry; metallurgy

Reducing beta-catenin expression to potentiate immunotherapy

#22 | 2019-03-07
US20190070180A1
Human necessities

Compositions and methods for the treatment of a beta-catenin-associated disease or disorder

InventorID:

2446145 ⎘